NOV

Forecast & Rating21 analysts currently cover NOV, with about 38.1% giving a positive rating — meaning they expect the stock to rise. The average price target is $21.75, about 7.7% upside from the current price of $20.19. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 51.0% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on NOV's outlook. Data as of Jul 27, 2026; for reference only and not investment advice.